Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor

Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor


TOKYO: A group of Takeda Pharmaceutical Co Ltd shareholders, who are trying to build support to block the US$62 billion acquisition of London-listed Shire Plc , failed to get a proposal passed at the drugmaker's annual general meeting on Thursday. The proposal - to require advance shareholder approval for large acquisitions - received about 10 percent of votes in favor, the company confirmed to Reuters, casting doubt on the group's ability to gather enough support to scupper the Shire deal.



from Biotech News